Clinical relevance of Mycobacterium malmoense isolation in the Netherlands

European Respiratory Journal

Volumn 34, Issue 4, 2009, Pages 926-931

  Hoefsloot, W ^a   Van Ingen, J ^a,b   De Lange, W C M ^a   Dekhuijzen, P N R ^a   Boeree, M J ^a   Van Soolingen, D ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Atypical mycobacteria; Atypical mycobacterium infections; Mycobacterium malmoense

Indexed keywords

AMIKACIN; AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; CLOFAZIMINE; CYCLOSERINE; ETHAMBUTOL; ISONIAZID; MACROLIDE; MOXIFLOXACIN; PROTIONAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFABUTIN; RIFAMPICIN; STREPTOMYCIN;

ADULT; AGED; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CERVICAL LYMPH NODE; CHRONIC OBSTRUCTIVE LUNG DISEASE; FEMALE; HUMAN; LUNG INFECTION; LUNG TUBERCULOSIS; LYMPHADENITIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MYCOBACTERIOSIS; MYCOBACTERIUM MALMOENSE; NETHERLANDS; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; THORAX RADIOGRAPHY; TREATMENT DURATION; TREATMENT RESPONSE; UNITED KINGDOM; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MORBIDITY; MYCOBACTERIA, ATYPICAL; MYCOBACTERIUM INFECTIONS, ATYPICAL; NETHERLANDS; RETROSPECTIVE STUDIES; TUBERCULOSIS, LYMPH NODE; TUBERCULOSIS, PULMONARY;

EID: 70349840697     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00039009     Document Type: Article

References (27)

1. Schröder KH, Juhlin I. Mycobacterium malmoense sp. nov. Int J Syst Bacteriol 1977; 27: 241-246. (Pubitemid 8149227)
2. Martín-Casabona N, Bahrmand AR, Bennedsen J, et al. Spanish Group for Non-Tuberculosis Mycobacteria. Non-tuberculous mycobacteria: patterns of isolation. A multi-country retrospective survey. Int J Tuberc Lung Dis 2004; 8: 1186-1193.
3. Griffith DE, Aksamit T, Brown-Elliot BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of non-tuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175: 367-416. (Pubitemid 46271561)
4. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society. Management of opportunistic mycobacterial infections: Joint Tuberculosis Committee guidelines 1999. Thorax 2000; 55: 210-218.
5. Portaels F. Epidemiology of mycobacterial diseases. Clin Dermatol 1995; 13: 207-222.
6. Primm TP, Lucero CA, Falkinham III JO. Health impacts of environmental mycobacteria. Clin Microbiol Rev 2004; 17: 98-106.
7. The Research Committee of the British Thoracic Society. Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow up of patients receiving standardised treatment. Eur Respir J 2003; 21: 478-482.
8. van Klingeren B, Dessens-Kroon M, van der Laan T, et al. Drug susceptibility testing of Mycobacterium tuberculosis complex by use of a high-throughput, reproducible, absolute concentration method. J Clin Microbiol 2007; 45: 2662-2668. (Pubitemid 47295501)
9. van Ingen J, Boeree MJ, de Lange WCM, et al. Clinical relevance of Mycobacterium szulgai in the Netherlands. Clin Infect Dis 2008; 46: 1200-1205.
10. van Ingen J, Boeree MJ, de Lange WCM, et al. Mycobacterium xenopi clinical relevance and determinants, the Netherlands. Emerg Infect Dis 2008; 14: 385-389.
11. Banks J, Jenkins PA, Smith AP. Pulmonary infection with Mycobacterium malmoense, a review of treatment and response. Tubercle 1985; 66: 197-203. (Pubitemid 16150079)
12. Bollert FGE, Watt B, Greening AP, et al. Non-tuberculous pulmonary infections in Scotland: a cluster in Lothian? Thorax 1995; 50: 188-190.
13. Thomson VØ, Andersen ÅB, Miörner H. Incidence and clinical significance of non-tuberculous mycobacteria isolated from clinical specimens during a 2-y nationwide survey. Scand J Infect Dis 2002; 34: 648-653.
14. Henriques B, Hoffner SE, Petrini B, et al. Infection with Mycobacterium malmoense in Sweden: report of 221 cases. Clin Infect Dis 1994; 18: 596-600. (Pubitemid 24106913)
15. Buchholz UT, McNeil MM, Keyes LE, et al. Mycobacterium malmoense infections in the United States, January 1993 through June 1995. Clin Infect Dis 1998; 27: 551-558.
16. Lewis KN, Liao R, Guinn KM, et al. Deletion of RD1 from Mycobacterium tuberculosis mimics Bacille Calmette-Guerin attenuation. J Infect Dis 2003; 187: 117-123. (Pubitemid 36034479)
17. Sorensen AL, Nagai S, Houen G, et al. Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect Immun 1995; 63: 1710-1717.
18. Rottman M, Catherinot E, Hochedez P, et al. Importance of T cells, gamma interferon, and tumor necrosis factor in immune control of the rapid grower Mycobacterium abscessus in C57BL/6 mice. Infect Immun 2007; 75: 5898-5907. (Pubitemid 350207829)
19. Doherty TM, Sher A. Defects in cell-mediated immunity affect chronic, but not innate, resistance of mice to Mycobacterium avium infection. J Immunol 1997; 158: 4822-4831. (Pubitemid 127483803)
20. Marras TK, Chedore P, Ying AM, et al. Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997-2003. Thorax 2007; 62: 661-666.
21. Hoefsloot W, Boeree MJ, van Ingen J, et al. The rising incidence and clinical relevance of Mycobacterium malmoense. Int J Tuberc Lung Dis 2008; 12: 987-993.
22. Doig C, Muckersie L, Watt B, et al. Molecular epidemiology of Mycobacterium malmoense infections in Scotland. J Clin Microbiol 2002; 40: 1103-1105. (Pubitemid 34208682)
23. Henry MT, Inamdar L, O'Riordain D, et al. Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response. Eur Respir J 2004; 23: 741-746. (Pubitemid 38618146)
24. Jenkins PA, Campbell IA, Banks J, et al. Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in the treatment of opportunist mycobacterial pulmonary diseases and an assessment of the value of immunotherapy with M. vaccae: a pragmatic, randomised trial by The British Thoracic Society. Thorax 2008; 63: 627-634.
25. Lindeboom JA, Prins JM, Bruijnesteijn van Coppenraet ES, et al. Cervicofacial lymphadenitis in children caused by Mycobacterium haemophilum. Clin Infect Dis 2005; 41: 1569-1575. (Pubitemid 41691594)
26. Lindeboom JA, Kuijper EJ, Bruijnesteijn van Coppenraet ES, et al. Surgical excision versus antibiotic treatment for nontuberculosis mycobacterial cervicofacial lymphadenitis in children: a multicenter, randomized, controlled trial. Clin Infect Dis 2007; 44: 1057-1064.
27. Olsen RJ, Cernoch PL, Land GA. Mycobacterial synovitis caused by slow-growing nonchromogenic species: eighteen cases and a review of the literature. Arch Pathol Lab Med 2006; 130: 783-791.